$2.5M for CorNova

Xconomy Boston — 

CorNova, a Burlington, MA-based developer of coronary stents with platinum surfaces, has raised $2.5 million of a proposed $6 million in equity financing, according to an SEC filing. The filing does not list the investors in the round, but peHUB writes that the firm’s previous investors include AdvanSource Biomaterials (formerly named CardioTech International) and Implant Sciences (AMEX:IMX), both of which are based in Wilmington, MA, as well as Siemens Venture Capital.